Saving changes...

Done

Error

Overview of Chemotherapy, Targeted Molecular Therapy, and Immunotheray

Overview of Chemotherapy, Targeted Molecular Therapy, and Immunotheray

Overview of Chemotherapy, Targeted Molecular Therapy, and Immunotheray

Dr. Shauna M. Birdsall, ND, FABNO & Dr. Tim Birdsall, ND, FABNO
Dr. Shauna M. Birdsall, ND, FABNO & Dr. Tim Birdsall, ND, FABNO
on behalf of National University of Health Sciences

$50.00 $ 50.00 $ 50.00

$FREE $ FREE $ FREE

$ 50.00 $ 50.00 $ 50.00
$ FREE $ FREE $ FREE
Normal Price: $50.00 FREE

Review:

Launch date: 28 Jan 2016
Expiry Date:

Last updated: 30 Apr 2018

Reference: 161925

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Naturopathic co-­‐management of patients diagnosed with malignancy has become increasingly more complex as new drugs are rapidly being approved by the FDA. This presentation will provide an overview of chemotherapy, targeted molecular therapy and immunotherapy (including new pharmaceutical agents), side effects, and naturopathic co-­‐management.

_______________

This course is valid for continuing education credit in the following states, so long as it falls within the scope of practice as outlined by the corresponding chiropractic state board:
CO, CT, DE, DC, GA, ID, IL, IA, MD, MI, MT, NE, OH, OR, RI, SC, UT, VT, VA, WA

This course is valid for continuing education credit in the following states, so long as it falls within the scope of practice as outlined by the corresponding naturopathic state board:
OR
If your state is not listed, please check approved continuing education through your respective state board, or contact our offices.

Please note that online continuing education is not recognized in the following states:
FL, IN, KY, LA, MS, OK, WI, WY

NUHS makes no representation either directly or indirectly that the substantive matter being presented is approved or within respective scope of licensing. It remains the attendees' responsibility to contact the state board(s) from which they seek continuing education credits for purposes of ensuring said board(s) approves both the delivery method and content as they relate to this event.

postgrad@nuhs.edu | (630) 889-6622

Objectives

Objective 1
Describe the principles of Naturopathic Co- management of oncology patients undergoing conventional cancer treatment
Objective 2
Understand pharmacology of common and recently approved chemotherapy drugs, targeted agents, monoclonal antibodies, and immunotherapy drugs, including indications and side effects
Objective 3
Recognize potential herb- drug nutrient interactions
Objective 4
Discuss the guidelines to prevent interactions
Objective 5
Identify naturopathic therapies to help manage side effects
Dr. Shauna M. Birdsall, ND, FABNO & Dr. Tim Birdsall, ND, FABNO

Author Information Play Video Bio

Dr. Shauna M. Birdsall, ND, FABNO & Dr. Tim Birdsall, ND, FABNO
on behalf of National University of Health Sciences

Naturopathic physician Dr. Shauna Birdsall provides customized naturopathic recommendations in conjunction with patients’ conventional oncology care at Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western). Dr. Birdsall is the Director of Naturopathic Medicine at Western and provides clinical oversight to both naturopathic physicians and acupuncturists. She is also the hospital’s Vice Chief of Staff.

Dr. Birdsall earned a bachelor's degree from the University of California, Davis. She later earned a doctor of naturopathic medicine degree from the National College of Natural Medicine in Portland, Oregon. Dr. Birdsall then completed a two-­‐year residency training program in naturopathic medicine and oncology at CTCA at Midwestern Regional Medical Center (Midwestern). She is also a Fellow of the American Board of Naturopathic Oncology.

Prior to joining the Western team, Dr. Birdsall spent eight years as a naturopathic clinician at Midwestern. There, she collaborated regularly with other CTCA clinicians to research the use of naturopathic therapies in cancer care. Her focus was on the safe, effective use of such natural therapies as vitamins, minerals, botanical medicines, amino acids and homeopathic remedies to help improve patients' quality of life.

Dr. Birdsall joined the Western team upon the hospital's opening in December 2008. On a personal level, she understands the challenges cancer patients and their families face. Dr. Birdsall's grandfather had MALT lymphoma, her grandmother is a colon cancer survivor and her father had prostate cancer.

Dr. Birdsall is an author of several research studies presented at major medical meetings. She has also been published in the journal Integrative Cancer Therapies. She is also a member of the Oncology Association of Naturopathic Physicians, the American Society for Clinical Oncology, the Society for Integrative Oncology and the American Association of Naturopathic Physicians. Dr. Timothy Birdsall is a visionary leader in integrative medicine. In 2009, he was recognized by the American Association of Naturopathic Physicians (AANP) as Physician of the Year, and in 2010 received the President’s Award of the Oncology Association of Naturopathic Physicians.

Dr. Birdsall was promoted to Senior Vice President of Information Services at Cancer Treatment Centers of America (CTCA) in 2013. He has also been serving as Chief Medical Information Officer since 2011. Dr. Birdsall is leading CTCA in clinical system enhancements and optimization to better serve our patients and those who provide care to our patients. Previously, he served as Vice President of Integrative Medicine, overseeing our unique treatment model, which combines state-­‐of-­‐the-­‐art conventional medical treatments with scientifically supported therapies such as nutrition therapy and naturopathic medicine.

A well-­‐known lecturer and naturopathic physician, Dr. Birdsall is a sought-­‐after presenter at medical conferences worldwide. He earned a doctorate degree in naturopathic medicine from Bastyr University, where he served on the faculty for five years. He is also a Fellow of the American Board of Naturopathic Oncology.

In January 2008, U.S. Health and Human Services Secretary Michael Leavitt appointed Dr. Birdsall to serve a four-­‐year term on the National Advisory Council for Complementary and Alternative Medicine for the National Institutes of Health (NIH).

Dr. Birdsall's professional achievements also include serving as Speaker of the House of Delegates and Vice President of the AANP. In addition, he currently serves on the board of directors of the Oncology Association of Naturopathic Physicians.

Dr. Birdsall was the founding Editor in Chief of Alternative Medicine Review, the first peer-­ reviewed medical journal edited by naturopathic doctors to be indexed on MEDLINE. He coauthored the book How To Prevent and Treat Cancer With Natural Medicine. Currently, Dr. Birdsall serves on the Editorial Consultants Board for the journal Integrative Cancer Therapies.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error